| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Qingqing Xu | Q64814766 |
| Chun-Shuo Shan | Q92314649 | ||
| Yi-Hua Shi | Q92314653 | ||
| Raymond Chuen-Chung Chang | Q41932816 | ||
| Guo-qing Zheng | Q42614367 | ||
| P2093 | author name string | Yong Wang | |
| Zi-Xian Chen | |||
| P2860 | cites work | Evidence of Experimental Bias in the Life Sciences: Why We Need Blind Data Recording | Q24288792 |
| A call for transparent reporting to optimize the predictive value of preclinical research | Q24289327 | ||
| Blood-brain barrier breakdown in acute and chronic cerebrovascular disease | Q27010013 | ||
| Targeting transporters: promoting blood-brain barrier repair in response to oxidative stress injury | Q28088708 | ||
| Pericytes regulate the blood-brain barrier | Q29615840 | ||
| The immunology of stroke: from mechanisms to translation | Q29620066 | ||
| Pooling of animal experimental data reveals influence of study design and publication bias | Q30918723 | ||
| Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal | Q33790988 | ||
| Increased BBB Permeability Enhances Activation of Microglia and Exacerbates Loss of Dendritic Spines After Transient Global Cerebral Ischemia | Q58801597 | ||
| Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research | Q83676243 | ||
| The protective roles of L-borneolum, D-borneolum and synthetic borneol in cerebral ischaemia via modulation of the neurovascular unit | Q88572265 | ||
| Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery? | Q33893813 | ||
| Effects of aromatic resuscitation drugs on blood brain barrier in cerebral ischemia-reperfusion injury model rats | Q34132212 | ||
| The blood-brain barrier in health and disease | Q34320420 | ||
| Use of angong niuhuang in treating central nervous system diseases and related research | Q34798924 | ||
| The blood-brain barrier | Q34931170 | ||
| Oxidative stress and antioxidant parameters in patients with major depressive disorder compared to healthy controls before and after antidepressant treatment: results from a meta-analysis | Q35844842 | ||
| Establishment and Dysfunction of the Blood-Brain Barrier | Q36306827 | ||
| Translational Stroke Research on Blood-Brain Barrier Damage: Challenges, Perspectives, and Goals. | Q36731242 | ||
| Inhibitory effects of monoterpenes on human TRPA1 and the structural basis of their activity | Q37469275 | ||
| Neurological diseases in relation to the blood-brain barrier | Q37976564 | ||
| Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke. | Q38046199 | ||
| Neuronal oxidative stress in acute ischemic stroke: sources and contribution to cell injury | Q38064214 | ||
| Evaluation of oxidative stress in patients with acute ischemic stroke | Q38167803 | ||
| Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. | Q38172752 | ||
| Blood-brain barrier breakdown and neovascularization processes after stroke and traumatic brain injury. | Q38592199 | ||
| Prediction of infarction volume and infarction growth rate in acute ischemic stroke | Q38633183 | ||
| Actin filament-associated protein 1 (AFAP-1) is a key mediator in inflammatory signaling-induced rapid attenuation of intrinsic P-gp function in human brain capillary endothelial cells | Q38719997 | ||
| Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges | Q38993027 | ||
| Pathogenic mechanisms following ischemic stroke | Q39247325 | ||
| Blood-brain barrier breakdown involves four distinct stages of vascular damage in various models of experimental focal cerebral ischemia | Q40515003 | ||
| The orally combined neuroprotective effects of sodium ferulate and borneol against transient global ischaemia in C57 BL/6J mice | Q42968166 | ||
| Stroke-induced blood-brain barrier breakdown along the vascular tree - No preferential affection of arteries in different animal models and in humans | Q46484268 | ||
| Sample Size Calculation in Animal Studies Using Resource Equation Approach | Q47553950 | ||
| Blood-brain barrier leakage increases with small vessel disease in acute ischemic stroke | Q47717834 | ||
| Blood-brain barrier dysfunction and recovery after ischemic stroke | Q47910464 | ||
| Endothelial progenitor cells enhance blood-brain barrier permeability in subacute stroke | Q47917429 | ||
| IL-23 (Interleukin-23)-Producing Conventional Dendritic Cells Control the Detrimental IL-17 (Interleukin-17) Response in Stroke | Q47929489 | ||
| A Review of the Catalytic Mechanism of Human Manganese Superoxide Dismutase. | Q48132597 | ||
| Penetration of verapamil across blood brain barrier following cerebral ischemia depending on both paracellular pathway and P-glycoprotein transportation | Q48300346 | ||
| Changes of pH and energy state in subacute human ischemia assessed by multinuclear magnetic resonance spectroscopy | Q48413700 | ||
| TRPC3/6/7 Knockdown Protects the Brain from Cerebral Ischemia Injury via Astrocyte Apoptosis Inhibition and Effects on NF-кB Translocation | Q48435745 | ||
| Apoptosis and Acute Brain Ischemia in Ischemic Stroke. | Q48437015 | ||
| The synergetic effect of edaravone and borneol in the rat model of ischemic stroke | Q48687849 | ||
| Antiepileptogenic effects of borneol in pentylenetetrazole-induced kindling in mice | Q48899024 | ||
| Protection by borneol on cortical neurons against oxygen-glucose deprivation/reperfusion: involvement of anti-oxidation and anti-inflammation through nuclear transcription factor κappaB signaling pathway | Q48945364 | ||
| MicroRNA-9 Mediates the Cell Apoptosis by Targeting Bcl2l11 in Ischemic Stroke | Q49159908 | ||
| 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association | Q49789131 | ||
| Therapeutic Potential of Pretreatment with Allograft Sertoli Cells Transplantation in Brain Ischemia by Improving Oxidative Defenses. | Q52650342 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | blood–brain barrier | Q221694 |
| brain ischemia | Q4862390 | ||
| borneol | Q27103499 | ||
| camphan monoterpenoid | Q107863299 | ||
| stroke | Q12202 | ||
| P304 | page(s) | 2936737 | |
| P577 | publication date | 2019-02-04 | |
| P1433 | published in | Oxidative medicine and cellular longevity | Q26840015 |
| P1476 | title | Borneol for Regulating the Permeability of the Blood-Brain Barrier in Experimental Ischemic Stroke: Preclinical Evidence and Possible Mechanism | |
| P478 | volume | 2019 |
| Q92970155 | Baicalein Exerts Neuroprotective Effects in FeCl3-Induced Posttraumatic Epileptic Seizures via Suppressing Ferroptosis |
| Q96771578 | Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia |
| Q99239557 | Preparation, Characterization and in vivo Study of Borneol-Baicalin-Liposomes for Treatment of Cerebral Ischemia-Reperfusion Injury |
| Q92257585 | The Potential Role of MicroRNA-124 in Cerebral Ischemia Injury |
Search more.